Small-Cell Lung Cancer Disease – Global Clinical Trials Review, H1 2020

GlobalData’s clinical trial report, “Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2020″ provides an overview of Small-Cell Lung Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Small-Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Bristol-Myers Squibb Co

GlaxoSmithKline Plc

AstraZeneca Plc

F. Hoffmann-La Roche Ltd

Novartis AG

Eli Lilly and Co

AbbVie Inc

Merck & Co Inc

Pfizer Inc

Amgen Inc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials 16

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials 19

Clinical Trials by Phase in E7 Countries 20

Clinical Trials in E7 Countries by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Clinical Trials by End Point Status 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Small-Cell Lung Cancer Therapeutics Clinical Trials 29

Prominent Drugs 30

Latest Clinical Trials News on Small-Cell Lung Cancer 31

Nov 11, 2019: ORYZON to present new data on iadademstat at Upcoming International Conferences 31

Nov 05, 2019: EpicentRx initiates dosing in phase 3 trial of immunotherapy RRx-001 for third-line Small Cell Lung Cancer 31

Oct 29, 2019: Harpoon Therapeutics presents preclinical data for HPN328, a DLL3-targeting T Cell Engager, at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 31

Oct 22, 2019: Harpoon Therapeutics announces presentation on HPN328 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 32

Oct 17, 2019: Sunshine Biopharma initiates Adva-27a Xenograft Studies in mice carrying different types of human cancer 32

Oct 16, 2019: Aileron Therapeutics announces the initiation of patient treatment in its first clinical Ph1b/2 trial of ALRN-6924 as a myelopreservation agent 32

Clinical Trial Profile Snapshots 34

Appendix 687

Abbreviations 687

Definitions 687

Research Methodology 688

Secondary Research 688

About GlobalData 689

Contact Us 689

Disclaimer 689

Source 690

List of Tables

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region, 2020* 8

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 9

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 10

Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020* 11

Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2020* 12

Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2020* 13

Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2020* 14

Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020* 15

Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2020* 16

Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 17

Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 18

Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2020* 19

Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 20

Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 21

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase, 2020* 22

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2020* 23

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2020* 24

Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2020* 25

Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26

Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020* 27

Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 28

Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 29

Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 30

List of Figures

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region, 2020* 8

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 9

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 10

Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020* 11

Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2020* 12

Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2020* 13

Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2020* 14

Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020* 15

Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2020* 16

Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 17

Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 18

Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2020* 19

Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 20

Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 21

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase, 2020* 22

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2020* 23

Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2020* 24

Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2020* 25

Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26

Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020* 27

Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 28

Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 29

Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 30

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports